Literature DB >> 10699162

Early expression of angiogenesis factors in acute myocardial ischemia and infarction.

S H Lee1, P L Wolf, R Escudero, R Deutsch, S W Jamieson, P A Thistlethwaite.   

Abstract

BACKGROUND: When the myocardium is deprived of blood, a process of ischemia, infarction, and myocardial remodeling is initiated. Hypoxia-inducible factor 1 (HIF-1) is a transcriptional activator of vascular endothelial growth factor (VEGF) and is critical for initiating early cellular responses to hypoxia. We investigated the temporal and spatial patterns of expression of the alpha subunit of HIF-1 (HIF-1alpha) and VEGF in specimens of human heart tissue to elucidate the early molecular responses to myocardial hypoxia.
METHODS: Ventricular-biopsy specimens from 37 patients undergoing coronary bypass surgery were collected. The specimens were examined by microscopy for evidence of ischemia, evolving infarction, or a normal histologic appearance. The specimens were also analyzed with the reverse-transcriptase polymerase chain reaction for HIF-1alpha and VEGF messenger RNA (mRNA) expression and by immunohistochemical analysis for the location of the HIF-1alpha and VEGF proteins.
RESULTS: HIF-1alpha mRNA was detected in myocardial specimens with pathological evidence of acute ischemia (onset, <48 hours before surgery) or early infarction (onset, <24 hours before surgery). In contrast, VEGF transcripts were seen in specimens with evidence of acute ischemia or evolving infarction (onset, 24 to 120 hours before surgery). Patients with normal ventricles or evidence of infarction in the distant past had no detectable levels of either VEGF mRNA or HIF-1alpha mRNA. HIF-1alpha immunoreactivity was detected in the nuclei of myocytes and endothelial cells, whereas VEGF immunoreactivity was found in the cytoplasm of endothelial cells lining capillaries and arterioles.
CONCLUSIONS: An increase in the level of HIF-1alpha is an early response to myocardial ischemia or infarction. This response defines, at a molecular level, one of the first adaptations of human myocardium to a deprivation of blood. HIF-1alpha is a useful temporal marker of acutely jeopardized myocardium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10699162     DOI: 10.1056/NEJM200003023420904

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  179 in total

1.  Endothelial expression of hypoxia-inducible factor 1 protects the murine heart and aorta from pressure overload by suppression of TGF-β signaling.

Authors:  Hong Wei; Djahida Bedja; Norimichi Koitabashi; Dongmei Xing; Jasper Chen; Karen Fox-Talbot; Rosanne Rouf; Shaoping Chen; Charles Steenbergen; John W Harmon; Harry C Dietz; Kathleen L Gabrielson; David A Kass; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-08       Impact factor: 11.205

Review 2.  Imaging of angiogenesis.

Authors:  Albert J Sinusas
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

Review 3.  Targeted metabolic imaging to improve the management of heart disease.

Authors:  Moritz Osterholt; Shiraj Sen; Vasken Dilsizian; Heinrich Taegtmeyer
Journal:  JACC Cardiovasc Imaging       Date:  2012-02

Review 4.  Angiogenic therapy for cardiac repair based on protein delivery systems.

Authors:  F R Formiga; E Tamayo; T Simón-Yarza; B Pelacho; F Prósper; M J Blanco-Prieto
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 5.  A-kinase anchoring proteins: getting to the heart of the matter.

Authors:  John D Scott; Luis F Santana
Journal:  Circulation       Date:  2010-03-16       Impact factor: 29.690

Review 6.  Complex role of the HIF system in cardiovascular biology.

Authors:  Gabor Czibik
Journal:  J Mol Med (Berl)       Date:  2010-06-24       Impact factor: 4.599

7.  Non-invasive Monitoring of Angiogenesis in Cardiology.

Authors:  Martin Rodriguez-Porcel
Journal:  Curr Cardiovasc Imaging Rep       Date:  2009-02

Review 8.  Unchain my heart: the scientific foundations of cardiac repair.

Authors:  Stefanie Dimmeler; Andreas M Zeiher; Michael D Schneider
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

9.  Phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury.

Authors:  John Doukas; Wolfgang Wrasidlo; Glenn Noronha; Elena Dneprovskaia; Richard Fine; Sara Weis; John Hood; Anthony Demaria; Richard Soll; David Cheresh
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-15       Impact factor: 11.205

10.  Advances in radionuclide molecular imaging in myocardial biology.

Authors:  Alan R Morrison; Albert J Sinusas
Journal:  J Nucl Cardiol       Date:  2010 Jan-Feb       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.